Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant

Pediatric Hematology and Oncology

Volumn 30, Issue 6, 2013, Pages 574-582

  Bielorai, Bella ^a   Fisher, Tamar ^a   Waldman, Dalia ^a   Lerenthal, Yaniv ^b   Nissenkorn, Andreea ^c   Tohami, Tali ^d   Marek, Dina ^e,f   Amariglio, Ninette ^b   Toren, Amos ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b Cancer Research Center   (Israel)

^c Pediatric Neurology Unit   (Israel)

^d Institute of Hematology   (Israel)

^e GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^f TEL AVIV UNIVERSITY   (Israel)

Author keywords

Ataxia telangiectasia variant; Leukemia; Mutation analysis

Indexed keywords

ATM PROTEIN; ZINOSTATIN; ANTINEOPLASTIC ANTIBIOTIC; ATM PROTEIN, HUMAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARAB; ARTICLE; ATAXIA; ATAXIA TELANGIECTASIA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CHILD; CHILDHOOD CANCER; FEMALE; FOCAL DYSTONIA; HUMAN; LYMPHOBLASTOID CELL LINE; MALE; MISSENSE MUTATION; PRESCHOOL CHILD; SCHOOL CHILD; SEQUENCE ANALYSIS; WESTERN BLOTTING; AGE; CASE REPORT; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; GENETICS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

ADULT; AGE FACTORS; ANTIBIOTICS, ANTINEOPLASTIC; ATAXIA TELANGIECTASIA; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MUTATION, MISSENSE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; ZINOSTATIN;

EID: 84881504493     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2013.777949     Document Type: Article

References (20)

1. Taylor AM, Metcalfe JA, Thick J, et al. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996;87:423-438. (Pubitemid 26030297)
2. Alterman N, Fattal-Valevski A, Moyal L, et al. Ataxia-telangiectasia: mild neurological presentation despite null ATMmutation and severe cellular phenotype. Am JMed Genet A. 2007;143A:1827-1834. (Pubitemid 47206057)
3. Gilad S, Chessa L, Khosravi R, et al. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet. 1998;62: 551-561. (Pubitemid 28164612)
4. Taylor AM, Byrd PJ.Molecular pathology of ataxia telangiectasia. J Clin Pathol. 2005;58:1009-1015. (Pubitemid 41416047)
5. Stewart GS, Maser RS, Stankovic T, et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell. 1999;99:577-587. (Pubitemid 30004634)
6. TaylorAM,GroomA,Byrd PJ.Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis. DNA Repair (Amst). 2004;3:1219-1225. (Pubitemid 38997965)
7. Fernet M, Gribaa M, Salih MA, et al. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum Mol Genet. 2005;14:307-318.
8. Peterson RD, Funkhouser JD, Tuck-Muller CM, et al. Cancer susceptibility in ataxia-telangiectasia. Leukemia. 1992;6 (Suppl 1): 8-13.
9. Stankovic T, Kidd AM, Sutcliffe A, et al. ATMmutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet. 1998;62:334-345. (Pubitemid 28110776)
10. Loeb DM, Lederman HM, Winkelstein JA. Lymphoid malignancy as a presenting sign of ataxiatelangiectasia. J Pediatr Hematol Oncol. 2000;22:464-467.
11. Yanofsky RA, Seshia SS, Dawson AJ, et al. Ataxia-telangiectasia: atypical presentation and toxicity of cancer treatment. Can J Neurol Sci. 2009;36:462-467.
12. Miller G, Robinson J, Heston L, et al. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. Proc Natl Acad Sci USA. 1974;71:4006-4010.
13. Sandoval N, Platzer M, Rosenthal A, et al. Characterization of ATM gene mutations in 66 ataxia telangiectasia families. HumMol Genet. 1999;8:69-79. (Pubitemid 29039050)
14. Becker-Catania SG, Chen G, Hwang MJ, et al. Ataxia-telangiectasia: phenotype/genotype studies of ATMprotein expression,mutations, and radiosensitivity. Mol Genet Metab. 2000;70:122-133. (Pubitemid 30460455)
15. Dork T, Bendix-Waltes R, Wegner RD, et al. Slow progression of ataxia-telangiectasia with double missense and in frame splicemutations. Am JMed Genet A. 2004;126A:272-277. (Pubitemid 38420639)
16. Silvestri G, Masciullo M, Piane M, et al. Homozygosity for c 6325T>G transition in the ATM gene causes an atypical, late-onset variant formof ataxia-telangiectasia. J Neurol. 2010;257:1738-1740.
17. Stewart GS, Last JI, Stankovic T, et al. Residual ataxia telangiectasiamutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T->Gmutations, showing a less severe phenotype. J Biol Chem. 2001;276:30133-30141.
18. Sutton IJ, Last JI, Ritchie SJ, et al. Adult-onset ataxia telangiectasia due to ATM 5762ins137mutation homozygosity. Ann Neurol. 2004;55:891-895. (Pubitemid 38702588)
19. Nissenkorn A, Levi YB, Vilozni D, et al. Neurologic presentation in children with ataxiatelangiectasia: is small head circumference a hallmark of the disease? J Pediatr. 2011;159:466-471.
20. Seif AE. Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis. Cancer Genet. 2004: 227-244.